Globe Life Inc. Profile Avatar - Palmy Investing

Globe Life Inc.

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Suppl…
Insurance - Life
US, McKinney [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 10.42 -453.96 -506.76
Graham Fair Price 2.20 57.20 55.97
PEG 0.74 -1.78 1.77
Price/Book -16.73 2.13 2.55
Price/Cash Flow 3.54 31.35 30.28
Prices/Earnings 1.09 10.54 10.42
Price/Sales -6.51 7.56 8.09
Price/FCF 3.54 31.35 30.28
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -0.11 0.93 0.94
Operating Margin -72.00 0.24 0.87
ROA -9.17 < 0.005 < 0.005
ROE 0.06 0.05 -17.63
ROIC 0.15 0.04 -75.29
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.12 -0.06 101.71
Dividends QOQ < 0.005 < 0.005 -98.78
EBIT QOQ 2.85 -0.72 -74.72
EPS QOQ 0.06 -0.06 0.35
FCF QOQ 0.37 -0.10 -73.88
Revenue QOQ 0.02 < 0.005 -98.61
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) -18327.13 -18279.50 0.26
Days Sales Outstanding (DSO) 40.07 41.05 2.47
Inventory Turnover < 0.005 < 0.005 -0.26
Debt/Capitalization 0.32 0.32 -0.36
Quick Ratio 0.62 0.46 -24.94
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 47.68 53.68 12.60
Cash 3.13 2.43 -22.27
Capex -0.14 -0.10 30.33
Free Cash Flow 4.02 3.64 -9.44
Revenue 15.04 15.09 0.29
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 0.80 0.62 -22.04
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -75.73 -79.66 -5.20
Naive Interpretation Member
06 - Financial Health · Bad
End of GL's Analysis
CIK: 320335 CUSIP: 37959E102 ISIN: US37959E1029 LEI: - UEI: -
Secondary Listings
GL has no secondary listings inside our databases.